Kiadis Pharma presented key data at EBMT 2016

Webcast of the full dataset on the primary endpoint of its single-dose Phase II trial with ATIR101™.

Watch full webcast

Key data from ongoing Phase II clinical trial with our lead product ATIR101™, presented in an oral presentation and two poster presentations at EBMT.

Read More

In this section you can find out more about our investor activities: company news releases, financial calendar, presentations, stock and shareholder information and latest financial reports.